Home

David Lamond, Director: Quince Therapeutics QNCX Buy · Filed 23/12/14

Trade details

Type
Insider buy
Amount
$22,627
Shares · price
22,627 sh · $1.00 a share
Held after
2,324,918 sh
Trade date
23/12/13
Filed
23/12/14
Days to filing
1 days

Holdings up 1.0%

Insiders buying this week
1 insiders
Holding change
+1.0%

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 23/11/13~24/01/12

David Lamond's recent trades

  • David Lamond

    BuyQuince Therapeutics

    $23.5K

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $22.8K

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $300

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $19.5K

    Filed 23/12/07

  • David Lamond

    BuyQuince Therapeutics

    $19.3K

    Filed 23/12/07

David Lamond, Director — bought $22.6K of Quince Therapeutics QNCX · 22,627 sh @ $1.00 | Whalegun